Anbio Biotechnology (NNNN) Assets Average (2024 - 2025)
Anbio Biotechnology (NNNN) posted Assets Average of $29.0 million for Q4 2025, up 24.29% on a QoQ basis from $23.3 million in Q2 2025, and up 66.77% year-over-year from $17.4 million in Q4 2024.
Powered by 
Analysis
Anbio Biotechnology (NNNN) Assets Average (2024 - 2025) Analysis & Trends
Anbio Biotechnology has reported Assets Average for 2 years, with the latest figure at $29.0 million in Q4 2025.
- On a quarterly basis, Assets Average rose 66.77% year-over-year to $29.0 million in Q4 2025; TTM through Dec 2025 was $29.0 million, a 66.77% increase from a year earlier, with the FY2025 full-year figure at $24.6 million, up 41.55% from the prior year.
- Assets Average was $29.0 million for Q4 2025 at Anbio Biotechnology, up from $23.3 million in the prior quarter.
- The five-year high for Assets Average was $29.0 million in Q4 2025, with the low at $17.4 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 37.19 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 2.38 Bn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 351.96 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 3.35 Bn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 284.46 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 172.21 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 1.09 Bn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | 28.96 Mn |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 5.67 Bn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 164.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 28.96 Mn |
| Jun 30, 2025 | 23.30 Mn |
| Dec 31, 2024 | 17.37 Mn |